PRGO News and Press, Perrigo Company plc From 10/15/19

DUBLIN , Oct. 15, 2019 /PRNewswire/ -- Perrigo Company plc (NYSE; TASE: PRGO), today announced that it will release its third quarter calendar year 2019 financial results on Wednesday, November 6, 2019 . The Company will host a conference call beginning at 8:00 a.m. (EDT) . The...

ALLEGAN, Mich. , Oct. 3, 2019 /PRNewswire/ --  Perrigo Company plc (NYSE; TASE: PRGO), a leading provider of  "Quality Affordable Self-Care Products ™ ", opened its doors for more than 175 high school students Thursday as part of Michigan Manufacturing Week . ...

DUBLIN , Oct. 3, 2019 /PRNewswire/ -- Perrigo Company plc (NYSE; TASE: PRGO) today announced the relaunch of the AB rated generic equivalent of Transderm Scop ® (scopolamine 1.5 mg). Annual market sales of Transderm Scop ® and therapeutic equivalents for the 12 months ending ...

After losing more than 77% of its total enterprise value in less than four years, Akorn, Inc. ( AKRX ) is a name to be followed carefully. The most significant risk is the company’s financial debt, which does not justify the current low valuation. Besides, Akorn recently announced tha...

With one product candidate at Phase 3 of development and expecting completion in early 2020, Aclaris Therapeutics ( ACRS ) is a name to be followed carefully. The Phase 3 trial is estimated to be completed on January 15, 2020. With that said, the company’s cash burn rate is very signifi...

Introduction The Dividend Champions list is a monthly compilation of companies which have consistently increased their annual dividend payouts, and the latest edition may be found here . However, since this list is only produced once per month, the data in it can quickly get out of date. Fu...

DUBLIN , Sept. 5, 2019 /PRNewswire/ -- Perrigo Company plc (NYSE; TASE: PRGO) announced today that it has entered into a definitive agreement to acquire the branded OTC rights to Prevacid ® from GlaxoSmithKline. Under the terms of the agreement, Perrigo will have the e...

The Trump administration has allocated $1.8B to help states and local governments tackle opioid addiction in their respective areas. The funds will be distributed through Substance Abuse and Mental Health Services and the CDC for treatment and data gathering. More news on: Teva Pharmaceu...

An Oklahoma district court has ordered Johnson & Johnson (NYSE: JNJ ) to pay $572M over its role in the opioid epidemic there. One-time co-defendants Purdue Pharma and Teva Pharmaceutical Industries (NYSE: TEVA ) settled earlier for $270M and $85M, respectively. More news on: John...

Introduction The Dividend Champions list is a monthly compilation of companies which have consistently increased their annual dividend payouts, and the latest edition may be found here . However, since this list is only produced once per month, the data in it can quickly get out of date. Fu...